{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:24:03Z","timestamp":1790270643895,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variation in disease course, but it is often progressive leading to increased breathlessness, impaired quality of life, and decreased life expectancy. Detection of pulmonary fibrosis is challenging, which contributes to considerable delays in diagnosis and treatment. More knowledge about the diagnostic journey from patients' perspective is needed to improve the diagnostic pathway. The aims of this study were to evaluate the time to diagnosis of pulmonary fibrosis, identify potential reasons for delays, and document patients emotions.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Members of European patient organisations, with a self-reported diagnosis of pulmonary fibrosis, were invited to participate in an online survey. The survey assessed the diagnostic pathway retrospectively, focusing on four stages: (1) time from initial symptoms to first appointment in primary care; (2) time to hospital referral; (3) time to first hospital appointment; (4) time to final diagnosis. It comprised open-ended and closed questions focusing on time to diagnosis, factors contributing to delays, diagnostic tests, patient emotions, and information provision.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Two hundred and seventy three participants (214 idiopathic pulmonary fibrosis, 28 sarcoidosis, 31 other) from 13 countries responded. Forty percent of individuals took \u22651 year to receive a final diagnosis. Greatest delays were reported in stage 1, with only 50.2% making an appointment within 3 months. For stage 2, 73.3% reported a hospital referral within three primary care visits. However, 9.9% reported six or more visits. After referral, 76.9% of patients were assessed by a specialist within 3 months (stage 3) and 62.6% received a final diagnosis within 3 months of their first hospital visit (stage 4). Emotions during the journey were overall negative. A major need for more information and support during and after the diagnostic process was identified.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The time to diagnose pulmonary fibrosis varies widely across Europe. Delays occur at each stage of the diagnostic pathway. Raising awareness about pulmonary fibrosis amongst the general population and healthcare workers is essential to shorten the time to diagnosis. Furthermore, there remains a need to provide patients with sufficient information and support at all stages of their diagnostic journey.<\/jats:p>","DOI":"10.3389\/fmed.2021.711194","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T08:13:04Z","timestamp":1628064784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European Survey"],"prefix":"10.3389","volume":"8","author":[{"given":"Iris G.","family":"van der Sar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bonella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Fourrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Bermudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Simidchiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina R.","family":"Strambu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies S.","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"190158","DOI":"10.1183\/16000617.0158-2019","article-title":"Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review","volume":"29","author":"Khor","year":"2020","journal-title":"Eur Respir Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"180077","DOI":"10.1183\/16000617.0077-2018","article-title":"The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype","volume":"27","author":"Olson","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4104\/pcrj.2010.00079","article-title":"Diagnostic assessment of patients with interstitial lung disease","volume":"20","author":"Gulati","year":"2011","journal-title":"Prim Care Respir J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12931-019-1076-0","article-title":"Risk factors for diagnostic delay in idiopathic pulmonary fibrosis","volume":"20","author":"Hoyer","year":"2019","journal-title":"Respir Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1183\/1393003.congress-2017.PA4880","article-title":"Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis? Real-world results from the EMPIRE registry","author":"Vasakova","year":"2017","journal-title":"Eur Respir J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.201104-0668OC","article-title":"Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study","volume":"184","author":"Lamas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12931-019-1228-2","article-title":"Diagnostic test interpretation and referral delay in patients with interstitial lung disease","volume":"20","author":"Pritchard","year":"2019","journal-title":"Respir Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-017-0560-x","article-title":"Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey","volume":"18","author":"Cosgrove","year":"2018","journal-title":"BMC Pulm Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"00124","DOI":"10.1183\/23120541.00124-2019","article-title":"Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a europe-wide survey","volume":"5","author":"Moor","year":"2019","journal-title":"ERJ Open Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.rmed.2006.10.002","article-title":"Patient experiences with pulmonary fibrosis","volume":"101","author":"Collard","year":"2007","journal-title":"Respir Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1479972311416382","article-title":"Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients","volume":"8","author":"Schoenheit","year":"2011","journal-title":"Chron Respir Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1183\/13993003.01204-2015","article-title":"European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers","volume":"47","author":"Bonella","year":"2016","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1513\/AnnalsATS.201806-376RL","article-title":"Potential delays in diagnosis of idiopathic pulmonary fibrosis in Medicare beneficiaries","volume":"16","author":"Mooney","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.rmed.2019.06.001","article-title":"Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015","volume":"155","author":"Sk\u00f6ld","year":"2019","journal-title":"Respir Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"00120","DOI":"10.1183\/23120541.00120-2020","article-title":"Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?","volume":"6","author":"Brereton","year":"2020","journal-title":"ERJ Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e000567","DOI":"10.1136\/bmjresp-2020-000567","article-title":"Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-pro registry","volume":"7","author":"Snyder","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1290339","DOI":"10.1080\/20018525.2017.1290339","article-title":"Are physicians in primary health care able to recognize pulmonary fibrosis?","volume":"4","author":"Purokivi","year":"2017","journal-title":"Eur Clin Respir J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1007\/s12325-020-01384-0","article-title":"The burden of progressive fibrosing interstitial lung disease: a DELPHI approach","volume":"37","author":"Wuyts","year":"2020","journal-title":"Adv Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4104\/pcrj.2012.00074","article-title":"Diagnostic pathways for interstitial lung diseases in primary care","volume":"21","author":"Heins","year":"2012","journal-title":"Prim Care Respir J"},{"key":"B21","unstructured":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1183\/09059180.00001914","article-title":"Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey","volume":"23","author":"Cottin","year":"2014","journal-title":"Eur Respir Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1183\/23120541.00187-2020","article-title":"Idiopathic pulmonary fibrosis in the United Kingdom: analysis of the british thoracic society electronic registry between 2013 and 2019","volume":"7","author":"Spencer","year":"2020","journal-title":"ERJ Open Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/09031936.00217614","article-title":"Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry","volume":"46","author":"Behr","year":"2015","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12931-021-01643-w","article-title":"Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study","volume":"22","author":"Poletti","year":"2021","journal-title":"Respir Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0197660","DOI":"10.1371\/journal.pone.0197660","article-title":"Patients' experiences of coping with Idiopathic Pulmonary Fibrosis and their recommendations for its clinical management","volume":"13","author":"Senanayake","year":"2018","journal-title":"PLOS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1183\/13993003.01566-2015","article-title":"The lived experience with idiopathic pulmonary fibrosis: a qualitative study","volume":"47","author":"Overgaard","year":"2016","journal-title":"Eur Respir J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.23750\/abm.v88i5-S.6870","article-title":"Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study","volume":"88","author":"Magnani","year":"2017","journal-title":"Acta Biomed"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e000207","DOI":"10.1136\/bmjoq-2017-000207","article-title":"Understanding the informational needs of patients with IPF and their caregivers: \u2018You get diagnosed, and you ask this question right away, what does this mean?","volume":"7","author":"Ramadurai","year":"2018","journal-title":"BMJ Open Qual"},{"key":"B31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.201512-2393OC","article-title":"Accuracy and reliability of internet resources for information on idiopathic pulmonary fibrosis","volume":"194","author":"Fisher","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2013-203808","article-title":"British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE","volume":"68","author":"Bolton","year":"2013","journal-title":"Thorax"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home oxygen therapy for adults with chronic lung disease. an official american thoracic society clinical practice guideline","volume":"202","author":"Susan","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. an official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"00235","DOI":"10.1183\/23120541.00235-2020","article-title":"Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review","volume":"7","author":"Hoffmann-Vold","year":"2021","journal-title":"ERJ Open Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12890-017-0468-5","article-title":"Unmet needs in the treatment of idiopathic pulmonary fibrosis\u2014insights from patient chart review in five European countries","volume":"17","author":"Maher","year":"2017","journal-title":"BMC Pulm Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12913-018-2868-5","article-title":"Implementing large scale fast track diagnostics in a comprehensive cancer center, pre- and post-measurement data","volume":"18","author":"van Harten","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12931-021-01676-1","article-title":"Educational aspects of rare and orphan lung diseases","volume":"22","author":"Alfaro","year":"2021","journal-title":"Respir Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.711194\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T08:13:07Z","timestamp":1628064787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.711194\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":40,"alternative-id":["10.3389\/fmed.2021.711194"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.711194","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"article-number":"711194"}}